Privilaged to be the only Asian faculty invited to speak in the #easl#HBVendpoints Workshop in London. Hope we can set a framework to guide #HBV drug developmemt and approval in the future.
#CROI2019 starts tomorrow. The meeting content is embargoed, so all you'll get for now are a few comments about the quirks of this great HIV scientific meeting. And yes, I mentioned the backpacks. Latest post: https://t.co/7sCTrlipBS
#HCV New Drugs: High response and re-infection rates among people who inject drugs treated for #hepatitis C in a community needle and syringe programme https://t.co/jo8GJvDAS6
Next week, we are reporting from the annual Conference on Retroviruses and Opportunistic Infections #CROI2019.
We'll be publishing news online and sending out four news bulletins in English, French, Spanish, Portuguese, Russian and Italian.
Sign up at: https://t.co/DJAfrn6h2I
#HCV New Drugs: MAVIRET - AbbVie reaches agreement with pan-Canadian for its #hepatitis C treatment MAVIRET™ - Ontario will be the first province to reimburse MAVIRET as of February 28, 2019 https://t.co/ScPKIBFEK6
What's HepCAPpening? Find out with our new weekly newsletter, covering hepatitis C-related news, events, advocacy, research and more, with a focus on the epidemic in Philadelphia. The inaugural issue lands in your inbox on Friday morning. Sign up now! https://t.co/xwH34seh3L